• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
    All News #Library
    Biotech

    Tourmaline Bio Unveils Phase 2 TRANQUILITY Trial Data at 2025

    GLOBENEWSWIRE

    Tourmaline Bio Q2 2025 Results and Business Highlights

    GLOBENEWSWIRE

    Tourmaline Sees Positive Phase 2 Data in CKD Inflammation Trial

    GLOBENEWSWIRE

    Tourmaline Bio to Present Phase 2 Trial Results on May 20, 2025

    GLOBENEWSWIRE

    Tourmaline Bio Reports Q1 2025 Financials and Business Highlights

    GLOBENEWSWIRE

    Tourmaline Bio Reports Q4 and Full Year 2024 Financial Results

    GLOBENEWSWIRE

    Tourmaline To Present At Leerink Partners 2025 Conference

    GLOBENEWSWIRE

    Tourmaline Bio To Present At Guggenheim SMID Cap Biotech

    GLOBENEWSWIRE

    Tourmaline Updates On Cardiovascular Focus At Investor Day

    GLOBENEWSWIRE

    Tourmaline Bio to Host Investor Day on Tuesday, December 10, 2024

    GLOBENEWSWIRE

    Tourmaline Bio Q3 2024 Results & Recent Business Updates

    GLOBENEWSWIRE

    Tourmaline To Host Webinar On IL-6 Inhibition In Cardio Disease

    GLOBENEWSWIRE

    Tourmaline To Showcase 2 Presentations At 2024 Cardiometabolic

    GLOBENEWSWIRE

    Tourmaline Bio Forms Cardiovascular Scientific Advisory Board

    GLOBENEWSWIRE

    Tourmaline Bio to Present at Upcoming Investor Conferences

    GLOBENEWSWIRE

    Tourmaline Bio Reports Q2 2024 Results And Business Highlights

    GLOBENEWSWIRE

    Tourmaline Bio Presents TRANQUILITY Study Design At ASPC Congress 2024

    GLOBENEWSWIRE

    Tourmaline Bio Doses First Patient In TOUR006 Cardiovascular Phase 2

    GLOBENEWSWIRE

    Tourmaline Bio Announces Key Milestones for Development of TOUR006

    GLOBENEWSWIRE

    Tourmaline Bio added to the NASDAQ Biotechnology Index

    GLOBENEWSWIRE

    Tourmaline Bio Announces FDA Clearance of IND Application for TOUR006

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.